The 21st Century Cures Act includes substantial changes to the FDA's regulation of medical devices. Bethany Hills, Chair of Mintz Levin's FDA Practice, discusses the impact on digital health products and the potential evolution of FDA regulation under Commissioner Scott Gottlieb.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.